Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2011-03-08
2011-03-08
Carr, Deborah D (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S063000
Reexamination Certificate
active
07902257
ABSTRACT:
The invention features methods for the preparation of naturally occurring trihydroxy polyunsaturated eicosanoids and their structural analogs. The invention further provides new derivatives and analogs of trihydroxy polyunsaturated eicosanoids that can be prepared according to these methods. The invention also provides compositions and methods using trihydroxy polyunsaturated eicosanoid derivatives for the prevention, amelioration and treatment of a variety of diseases or conditions associated with inflammation or inflammatory response, autoimmune diseases, rheumatoid arthritis, cardiovascular diseases, or abnormal cell proliferation or cancer.
REFERENCES:
patent: 4201211 (1980-05-01), Chandrasekaran et al.
patent: 4442099 (1984-04-01), Nicolau et al.
patent: 4567290 (1986-01-01), Nicolau et al.
patent: 4576758 (1986-03-01), Morris et al.
patent: 4666701 (1987-05-01), Horrobin et al.
patent: 4710521 (1987-12-01), Soukup et al.
patent: 4759880 (1988-07-01), Nicolau et al.
patent: 4810424 (1989-03-01), Gerwick et al.
patent: 5087790 (1992-02-01), Petasis et al.
patent: 5136501 (1992-08-01), Silverman et al.
patent: 5177046 (1993-01-01), Savoca et al.
patent: 5409955 (1995-04-01), Bockow et al.
patent: 5411988 (1995-05-01), Bockow et al.
patent: 5441951 (1995-08-01), Serhan
patent: 5594732 (1997-01-01), Bell et al.
patent: 5604258 (1997-02-01), Ferrante et al.
patent: 5648512 (1997-07-01), Serhan
patent: 5650157 (1997-07-01), Bockow
patent: 5709855 (1998-01-01), Bockow et al.
patent: 5752238 (1998-05-01), Dedrick
patent: 5756789 (1998-05-01), Bruce et al.
patent: 5814599 (1998-09-01), Mitragotri et al.
patent: 5842040 (1998-11-01), Hughes et al.
patent: 5845265 (1998-12-01), Woolston
patent: 5846974 (1998-12-01), Kallman et al.
patent: 5861399 (1999-01-01), Seed et al.
patent: 5870717 (1999-02-01), Wiecha
patent: 5878400 (1999-03-01), Carter, III
patent: 5878423 (1999-03-01), Anderson et al.
patent: 5890138 (1999-03-01), Godin et al.
patent: 5896379 (1999-04-01), Haber
patent: 5912006 (1999-06-01), Bockow et al.
patent: 5932598 (1999-08-01), Talley et al.
patent: 5946467 (1999-08-01), Pathakis et al.
patent: 6030715 (2000-02-01), Thompson et al.
patent: 6030917 (2000-02-01), Weinberg et al.
patent: 6048897 (2000-04-01), Serhan
patent: 6069109 (2000-05-01), Kao et al.
patent: 6117911 (2000-09-01), Grainger et al.
patent: 6201022 (2001-03-01), Mease et al.
patent: 6232467 (2001-05-01), Petasis et al.
patent: 6259699 (2001-07-01), Opalka et al.
patent: 6272474 (2001-08-01), Garcia
patent: 6316648 (2001-11-01), Serhan
patent: 6336105 (2002-01-01), Conklin et al.
patent: 6336138 (2002-01-01), Caswell et al.
patent: 6377937 (2002-04-01), Paskowitz
patent: 6397212 (2002-05-01), Biffar
patent: 6415270 (2002-07-01), Rackson et al.
patent: 6427132 (2002-07-01), Bowman-Amuah
patent: 6428990 (2002-08-01), Mukerji et al.
patent: 6569075 (2003-05-01), Serhan
patent: 6602817 (2003-08-01), Petasis
patent: 6620919 (2003-09-01), Serhan
patent: 6635776 (2003-10-01), Serhan
patent: 6653493 (2003-11-01), Serhan
patent: 6670396 (2003-12-01), Serhan et al.
patent: 6750360 (2004-06-01), Serhan
patent: 6887901 (2005-05-01), Serhan
patent: 6949664 (2005-09-01), Petasis
patent: 7030159 (2006-04-01), Serhan et al.
patent: 7053230 (2006-05-01), Serhan et al.
patent: 7341840 (2008-03-01), Serhan et al.
patent: 7582785 (2009-09-01), Petasis et al.
patent: 7585856 (2009-09-01), Serhan et al.
patent: 2001/0023500 (2001-09-01), Serhan
patent: 2001/0031882 (2001-10-01), Serhan
patent: 2002/0010351 (2002-01-01), Serhan
patent: 2002/0045579 (2002-04-01), Madara et al.
patent: 2002/0055538 (2002-05-01), Serhan et al.
patent: 2002/0055539 (2002-05-01), Bockow et al.
patent: 2002/0082435 (2002-06-01), Serhan
patent: 2002/0091279 (2002-07-01), Serhan
patent: 2002/0094549 (2002-07-01), Serhan et al.
patent: 2002/0107289 (2002-08-01), Serhan
patent: 2002/0111505 (2002-08-01), Serhan
patent: 2002/0120013 (2002-08-01), Serhan
patent: 2002/0132847 (2002-09-01), Serhan
patent: 2002/0143069 (2002-10-01), Serhan
patent: 2002/0193431 (2002-12-01), Serhan et al.
patent: 2003/0032827 (2003-02-01), Serhan
patent: 2003/0055275 (2003-03-01), Serhan
patent: 2003/0060512 (2003-03-01), Madara et al.
patent: 2003/0069435 (2003-04-01), Serhan
patent: 2003/0134901 (2003-07-01), Serhan
patent: 2003/0166716 (2003-09-01), Serhan et al.
patent: 2003/0191184 (2003-10-01), Serhan et al.
patent: 2003/0191332 (2003-10-01), Serhan
patent: 2003/0195248 (2003-10-01), Serhan et al.
patent: 2003/0236423 (2003-12-01), Petasis
patent: 2004/0019110 (2004-01-01), Van Dyke et al.
patent: 2004/0044050 (2004-03-01), Goodman et al.
patent: 2004/0053998 (2004-03-01), Serhan et al.
patent: 2004/0059144 (2004-03-01), Serhan et al.
patent: 2004/0440287 (2004-03-01), Obukowicz
patent: 2004/0116408 (2004-06-01), Serhan
patent: 2004/0151712 (2004-08-01), Madara et al.
patent: 2004/0192785 (2004-09-01), Serhan
patent: 2005/0075398 (2005-04-01), Bazan et al.
patent: 2005/0228047 (2005-10-01), Petasis
patent: 2005/0238589 (2005-10-01), Van Dyke et al.
patent: 2005/0261255 (2005-11-01), Serhan et al.
patent: 2006/0128804 (2006-06-01), Serhan et al.
patent: 2006/0293288 (2006-12-01), Serhan et al.
patent: 2008/0096961 (2008-04-01), Serhan et al.
patent: 2009/0149538 (2009-06-01), Serhan et al.
patent: 2009/0156673 (2009-06-01), Serhan et al.
patent: 2009/0180961 (2009-07-01), Serhan et al.
patent: 2009/0291916 (2009-11-01), Petasis
patent: 0736509 (1996-10-01), None
patent: 2033745 (1980-05-01), None
patent: 5186342 (1993-07-01), None
patent: WO 91/16914 (1991-11-01), None
patent: WO 97/19415 (1997-05-01), None
patent: WO 98/19259 (1998-05-01), None
patent: WO 98/35469 (1998-08-01), None
patent: WO 98/46588 (1998-10-01), None
patent: WO 99/06913 (1999-02-01), None
patent: WO 99/13417 (1999-03-01), None
patent: WO 00/74632 (1999-06-01), None
patent: WO 99/56727 (1999-11-01), None
patent: WO 00/32210 (2000-06-01), None
patent: WO 01/60778 (2001-08-01), None
patent: WO 03/051350 (2003-06-01), None
patent: WO 03/053123 (2003-07-01), None
patent: WO 03/053423 (2003-07-01), None
patent: WO 03/084305 (2003-10-01), None
patent: WO 03/105776 (2003-12-01), None
patent: WO 2004/014835 (2004-02-01), None
patent: WO 2005/089744 (2005-09-01), None
“Scope and Editorial Policy”,Organometallics, published by the American Chemical Society 21 (1) 2002, 13A, 14A.
“Epolinsatures”, Bulletin De La Societe Chimique de France, No. 3, pp. 419-432, 1989.
XP002184773. Database WPI, Section Ch, Week 199334. Derwent Publications Ltd., London, GB; Class B05, AN 1993-269748. (See also JP 05186342, Jul. 27, 1993).
Alami, et al., A Versatile Route to conjugated hydroxyl (e,z,e,e)—Tetraenoic acids: highly chemo-and stereoselective synthesis of lipoxin B4 Tetrahedro Asym., 8 (17) 1997, pp. 2949-2958.
Albert, C. M. et al., “Blood levels of long-chain n-e fatty acids and the risk of sudden death”,N. Engl. J. Med., vol. 346, 2002, pp. 1113-1118.
Arita et al., “Stereochemical Assignment, Antiinflammatory Properties, and Receptor for the Omega-3 Lipid Mediator Resolvin E1”,J. Exp. Med.201(5) 2005, 713-722.
Arita, et al., “Resolvin E1, An Endogenous Lipid Mediator Derived from Omega-3 Eicosapentaenoic Acid, Protects Against 2, 4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis”,Proc. Natl. Acad. Sci, USA, 102(21) 2005, pp. 7671-7676.
Babine, R.E. and S.L. Bender., “Molecular Recognition of Protein-Ligand Complexes: Applications to Design”,Chem. Rev.97, 1997, pp. 1359-1472.
Bandeira-Mielo et al., “Cyclooxygenase—2 derived prostaglandin E2and lipoxin A4accelerate resolution of allergic edema in Antiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia”,J. Immunol., vol. 164, 2000, pp. 1029-1036.
Bannenberg, et al., “Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins”,Immunol.174(7) 2005, pp. 4345-4355.
Bazan, et al., “Docosahexaneoic Acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina”,Bio
Carr Deborah D
Fairman Colin L.
Fulbright & Jaworski
Rothenberger Scott D.
University of Southern California
LandOfFree
Trihydroxy polyunsaturated eicosanoid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trihydroxy polyunsaturated eicosanoid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trihydroxy polyunsaturated eicosanoid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2658727